STAT

JULY 7, 2023

Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio

Hospitals 308

Hospitals 308

PharmaVoice

JULY 7, 2023

Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.

246

246

STAT

JULY 7, 2023

As part of the Biden administration’s broader efforts to lower health care costs, the White House announced new guidelines on Friday targeting a few of the most common sources of sticker shock. The new policy initiatives target some of the usual suspects: surprise billing , which was restricted in 2020 yet persists as health care providers exploit loopholes ; short-term insurance policies that often fail to cover essential treatment; and high-interest credit cards and payment plans especi

Hospitals 248

Hospitals 248

PharmExec

JULY 7, 2023

Through the power of large language models and generative AI, pharma and biotech companies are transforming medical information delivery by offering direct, trustworthy, and accurate answers to patients and healthcare providers, significantly reducing time and frustration.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 7, 2023

The recent FDA approval of Leqembi , the latest anti-amyloid drug, is undoubtedly a breakthrough for the field, providing a new way to slow the advancement of mild cognitive impairment or early-stage Alzheimer’s disease. As a practicing geriatrician who has treated Alzheimer’s patients for more than 40 years and the co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation, I have never been more optimistic about our potential to transform how we trea

247

247

The Pharmacist

JULY 7, 2023

With a recent study in the BMJ suggesting an increased risk of dementia in those using hormone replacement therapy (HRT), should women now peel off their patches? Rod Tucker investigates, in the first in a Review series of articles for the Pharmacist. The menopause represents a normal physiological change that occurs on average in women […] The post HRT and the risk of dementia: Should users be worried?

98

98

Pharma Times

JULY 7, 2023

Second dose of treatment generates response among young people during Oxford University trial - News - PharmaTimes

Immunity 117

Immunity Immunization Vaccines 117

STAT

JULY 7, 2023

WASHINGTON — A House subcommittee will next week mark up a package of public health bills, including pandemic-preparedness legislation, according to five lobbyists. The House Energy & Commerce Committee hasn’t yet announced the markup, and the lobbyists didn’t know the exact date. But time is running out for reauthorizing a law that created several of the federal government’s biodefense and pandemic-preparedness programs.

Packaging 207

Packaging 207

PharmExec

JULY 7, 2023

While large pharma investment in biotechs is down—as pharmas become more strategic in their selections—it is scarcely out, with the partnership dynamic between the two sides remaining strong.

97

97

STAT

JULY 7, 2023

WASHINGTON (AP) — President Biden on Friday rolled out a new set of initiatives to reduce health care costs: a crackdown on scam insurance plans, new guidance to prevent surprise medical bills and an effort to reduce medical debt tied to credit cards. Biden’s remarks will build on previous initiatives to limit health care costs, with the Department of Health and Human Services releasing new estimates showing 18.7 million older adults and other Medicare beneficiaries will save an es

Hospitals 196

Hospitals 196

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

JULY 7, 2023

Scientists have created paracetamol and ibuprofen, two of the world’s most common painkillers, out of turpentine (β-pinene), a compound found in pine trees. Turpentine is also a waste product from the paper industry. According to the research published in the journal ChemSusChem , the quantity of this waste generated worldwide is enough to supply the global demand for paracetamol and ibuprofen.

Compounding 94

Compounding 94

STAT

JULY 7, 2023

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.  Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from

Hospitals 195

Hospitals 195

The Pharmacist

JULY 7, 2023

More than 15% of community pharmacies in England have signed up to provide the NHS Pharmacy Contraception Service, The Pharmacist can reveal. According to figures from the NHS Business Services Authority, 1,748 pharmacies signed up to provide the service between 24 April, when sign-up for the service opened, and 18 June. This equates to of […] The post Exclusive: More than 15% of pharmacies sign up to provide contraception service appeared first on The Pharmacist.

Community Pharmacies 90

Community Pharmacies 90

STAT

JULY 7, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

150

150

Express Pharma

JULY 7, 2023

Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions. Published in Nature Medicine, the latest report contains important new data on infection rates, disease severity and deaths in the patient groups, who we

Immunity 87

Immunity Immunization Vaccines Hospitals 87

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Compounding 87

Compounding Pharmaceutical Companies Pharmaceutical Companies 87

Pharma Times

JULY 7, 2023

Therapy involves the treatment of non-segmental vitiligo among adults and adolescents - News - PharmaTimes

105

105

Drug Channels

JULY 7, 2023

Today’s guest post comes from Sahil Naik, Chief of Staff to the CEO at Phil, Inc. Sahil discusses how manufacturers can balance patients’ access to therapy with gross-to-net (GTN) goals. Visit [link] to learn more about how Phil helps improve the patient experience while managing GTN. Read on for Sahil’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

77

77

Express Pharma

JULY 7, 2023

Diversity, equity and inclusion (DE&I) are fundamental principles that drive positive change and progress in various aspects of society. These principles recognise and celebrate the unique characteristics and experiences of individuals, ensuring fair representation, equal access, and opportunities for all. In the context of clinical research, diversity refers to the inclusion of individuals from various demographic backgrounds, including race, ethnicity, gender, age, socioeconomic status, an

Medical Schools 74

Medical Schools 74

Outsourcing Pharma

JULY 7, 2023

The first and only approved anti-amyloid Alzheimer's Disease (AD) treatment shown to reduce the rate of disease progression and slow cognitive impairment has been granted approval by the FDA.

98

98

Pharmaceutical Technology

JULY 7, 2023

As quarterly antidepressant prescriptions hit 22 million, the NHS looks to cut down patient reliance.

98

98

Outsourcing Pharma

JULY 7, 2023

Anorexia nervosa is a notoriously difficult illness to treat. It has the highest mortality rate of any psychiatric disorder, yet there is currently no FDA approved therapy for the condition.

97

97

The Guardian - Pharmaceutical Industry

JULY 7, 2023

Exclusive: Regulators investigate after patients harmed by unlicensed treatment from firm paid millions by NHS A cancer patient has died and three others have been hospitalised after they were administered unlicensed versions of chemotherapy by Sciensus, a private company paid millions by the NHS to provide essential medication, the Guardian can reveal.

Chemotherapy 76

Chemotherapy 76

PharmExec

JULY 7, 2023

Attempts to capitalize on the region’s vibrant R&D scene are heating up.

98

98

pharmaphorum

JULY 7, 2023

RxPreferred to offer Humira biosimilar through Mark Cuban's online pharmacy Eloise.

Online Pharmacies 87

Online Pharmacies Biosimilars 87

Pharmaceutical Technology

JULY 7, 2023

AC-0676 is under clinical development by Accutar Biotechnology and currently in Phase I for Follicular Lymphoma.

75

75

pharmaphorum

JULY 7, 2023

Changing Faces: Pharma and biotech hires from May & June 2023 Mike.

91

91

Putting Patients First Blog

JULY 7, 2023

The NHC Releases Research Brief and Infographic on COVID-19 Vaccine Technology and Hesitancy July 7, 2023 By: Lillian L.Q. Witting, MPH, Coordinator, Research, Education, and Programs Vaccinations are a major accomplishment of the 20th century. Despite this accomplishment, the COVID-19 pandemic exposed the inadequacy of the health care system to respond to public health emergencies.

Vaccines 52

Vaccines Immunity Immunization 52

pharmaphorum

JULY 7, 2023

America’s mental health crisis: Why we need a Moonshot Mike.

94

94

Outsourcing Pharma

JULY 7, 2023

OSP spoke to senior director of clinical trials, Erin Leckrone, and Kathleen Kane, senior manager of clinical operations at Be The Match Biotherapies, to discuss how creating a well-designed and reviewed protocol is critical to a study's overall success.

52

52

pharmaphorum

JULY 7, 2023

Novavax secures full EU approval for COVID-19 vaccine Nuvaxovid Eloise.

Vaccines 85

Vaccines 85

Definitive Healthcare

JULY 7, 2023

Artificial intelligence and machine learning for medical device companies mgathers Fri, 07/07/2023 - 09:23 Teaser Image Artificial-intelligence-and-machine-learning-for-medical-device-companies.png Teaser Content Uncover the operational implications of AI and ML for medtech and medical device teams’ strategic decision-making. Resource Type E-Books & How-To Guides Buyer's Guide eBook eBook Healthcare data & analytics buying guide for medical device firms Launching your medical device: A strategy

52

52

Pharmaceutical Business Review

JULY 7, 2023

The full MA is based on positive opinion received from the European Medicines Agency’s Committee for Medicinal Products for Human Use, and replaces the conditional Marketing Authorization. As the EC has now granted full approval, the protein-based vaccine can be used as a primary series in people aged 12 and above for the prevention of Covid-19. It can also be taken as a booster dose in adults aged 18 and older.

Vaccines 52

Vaccines 52

Syner-G

JULY 7, 2023

Personalized medicine is truly that. Based on an individual’s unique genetic profile, it’s used to make precise decisions according to that person’s biologically predetermined factors, and guides the optimum approach to disease prevention, diagnosis, and treatment. It determines the most appropriate medications or therapies and administers them.

Medical Records 52

Medical Records Dosage Drug Development 52

Pharmaceutical Commerce

JULY 7, 2023

Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.

52

52